ADVENZYMES:NSE-Advanced Enzyme Technologies Limited (INR)

COMMON STOCK | Specialty Chemicals | NSE

Last Closing Price

INR 308.05

Change

0.00 (0.00)%

Market Cap

INR 34.42B

Volume

0.13M

Average Target Price

INR 425.00 (+37.96%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Advanced Enzyme Technologies Limited researches and develops, manufactures, and markets enzymes and probiotics in India, the United States, Asia, Europe, and internationally. The company offers enzymes for human healthcare and animal nutrition; and enzymes for fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as for specialty applications. It also provides non-food processing enzymes for textile processing, leather, pulp and paper, detergents and cleaning aids, bio-fuels, and biocatalysis. The company was formerly known as Advanced Biochemicals Limited and changed its name to Advanced Enzyme Technologies Limited in 2005. Advanced Enzyme Technologies Limited was founded in 1957 and is based in Thane, India. Address: Sun Magnetica, Thane, India, 400604

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-01-26 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ASIANPAINT:NSE Asian Paints Limited

N/A

INR2,411.95B 87.74 52.47
PIDILITIND:NSE Pidilite Industries Limited

N/A

INR897.14B 101.72 61.19
BERGEPAINT:NSE Berger Paints India Limited

N/A

INR726.24B 139.30 80.44
KANSAINER:NSE Kansai Nerolac Paints Limited

N/A

INR329.50B 85.58 45.87
SRF:NSE SRF Limited

N/A

INR319.17B 31.08 18.57
AARTIIND:NSE Aarti Industries Limited

N/A

INR199.57B 42.23 24.24
ATUL:NSE Atul Ltd

N/A

INR193.56B 32.14 19.25
SUMICHEM:NSE Sumitomo Chemical India Limite..

N/A

INR153.39B 58.89 36.29
CASTROLIND:NSE Castrol India Limited

N/A

INR126.61B 18.98 12.02
VINATIORGA:NSE Vinati Organics Limited

N/A

INR122.69B 44.50 32.15

ETFs Containing ADVENZYMES

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.51% 24% F 22% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.51% 24% F 22% F
Trailing 12 Months  
Capital Gain 77.60% 83% B 85% B
Dividend Return 0.17% 19% F 11% F
Total Return 77.77% 83% B 85% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -7.11% 23% F 34% F
Dividend Return 0.16% 7% F 12% F
Total Return -6.95% 21% F 33% F
Risk Return Profile  
Volatility (Standard Deviation) 38.03% 52% F 51% F
Risk Adjusted Return -18.28% 29% F 34% F
Market Capitalization 34.42B 75% C 73% C
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 25.27 46% F 40% F
Price/Book Ratio 4.08 30% F 20% F
Price / Cash Flow Ratio 24.43 30% F 18% F
EV/EBITDA 15.50 45% F 40% F
Management Effectiveness  
Return on Equity 16.58% 75% C 83% B
Return on Invested Capital 16.65% 78% C+ 88% B+
Return on Assets 12.58% 92% A- 95% A
Debt to Equity Ratio 0.40% 87% B+ 80% B-
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.17 96% A 96% A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (INR)

Quarterly Financials (INR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.